The European Commission (EC) has granted approval for Keytruda (pembrolizumab) in combination with paclitaxel, with or without bevacizumab, as a…
Read More

The European Commission (EC) has granted approval for Keytruda (pembrolizumab) in combination with paclitaxel, with or without bevacizumab, as a…
Read More
ImmunityBio has achieved a significant regulatory victory with the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative Region, China,…
Read More